Higher allele burden of somatic mutations in the CD34+ cells has been associated with overall more aggressive MDS sub-types [54] and congruence of the JAK2V617F CD34+ progenitor and neutrophil allele burdens in MPN patients has been correlated with more advanced disease and MF phenotype [55]. The gene discussed is CD34; the disease is myeloproliferative neoplasm.